Heron Therapeutics, Inc. /DE/ SEC filings HRTX

Heron Therapeutics, Inc. /DE/ has 1,000 filings in SEC EDGAR's recent list, going back to Jun 2, 2011. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.

Heron Therapeutics, Inc. /DE/ SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Oct 27, 2026 —
8-K Current report
Material agreement
Sep 29, 2026 Sep 23, 2026
8-K Current report
Material agreement, Change to shareholder rights
Aug 14, 2026 Aug 13, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Listing notice
Jun 25, 2026 Jun 25, 2026
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 11, 2026
8-K Current report
Other events
Jun 2, 2026 Jun 2, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
PRE 14A Preliminary proxy statement Apr 20, 2026 Apr 20, 2026
8-K Current report
Officer or director change
Apr 6, 2026 Apr 3, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure
Jan 9, 2026 Jan 9, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 29, 2025 Oct 27, 2025
8-K Current report
Shareholder vote results
Oct 15, 2025 Oct 15, 2025
DEF 14A Proxy statement Sep 19, 2025 Oct 13, 2025
EFFECT Filing Sep 16, 2025 —
EFFECT Filing Sep 16, 2025 —
CORRESP Letter to the SEC Sep 12, 2025 —
CORRESP Letter to the SEC Sep 12, 2025 —
UPLOAD Letter from the SEC Sep 11, 2025 —
UPLOAD Letter from the SEC Sep 11, 2025 —
S-3 Shelf registration Sep 9, 2025 —
S-3 Shelf registration Sep 9, 2025 —
PRE 14A Preliminary proxy statement Sep 9, 2025 Sep 9, 2025
8-K Current report
Material agreement
Aug 28, 2025 Aug 22, 2025
8-A12B Filing Aug 15, 2025 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
Aug 15, 2025 Aug 13, 2025
8-K Current report
Material agreement, Bylaw or fiscal year change, Other events
Aug 12, 2025 Aug 8, 2025
8-K Current report
Material agreement
Aug 12, 2025 Aug 6, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Other events
Aug 8, 2025 Aug 8, 2025
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 12, 2025
S-8 Employee stock plan registration May 6, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
8-K Current report
Other events
May 6, 2025 May 6, 2025
DEFA14A Additional proxy material Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
8-K Current report
Officer or director change
Apr 29, 2025 Apr 28, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Material agreement
Feb 20, 2025 Feb 13, 2025
8-K Current report
Regulation FD disclosure
Dec 23, 2024 Dec 23, 2024
8-K Current report
Other events
Dec 3, 2024 Dec 3, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Regulation FD disclosure
Jul 2, 2024 Jul 2, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 18, 2024 Jun 13, 2024
8-K Current report
Regulation FD disclosure
May 29, 2024 May 29, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 Jun 13, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 13, 2024
8-K Current report
Officer or director change
Mar 21, 2024 Mar 18, 2024
10-K Annual report Mar 12, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
8-K Current report
Other events
Jan 24, 2024 Jan 23, 2024
8-K Current report
Material agreement
Jan 11, 2024 Jan 5, 2024
8-K Current report
Other events
Dec 22, 2023 Dec 18, 2023
8-K Current report
Officer or director change
Dec 21, 2023 Dec 20, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
424B3 Prospectus Sep 6, 2023 —
EFFECT Filing Aug 31, 2023 —
CORRESP Letter to the SEC Aug 30, 2023 —
UPLOAD Letter from the SEC Aug 28, 2023 —
S-3 Shelf registration Aug 23, 2023 —
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
D Filing Aug 1, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Jul 24, 2023 Jul 21, 2023
S-8 Employee stock plan registration Jun 30, 2023 —
8-K Current report
Officer or director change
Jun 23, 2023 Jun 16, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 12, 2023 Jun 6, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEF 14A Proxy statement May 1, 2023 Jun 8, 2023
PRE 14A Preliminary proxy statement Apr 20, 2023 Jun 8, 2023
8-K Current report
Officer or director change
Apr 20, 2023 Apr 18, 2023
8-K Current report
Officer or director change
Apr 3, 2023 Mar 30, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
8-K Current report
Other events
Mar 6, 2023 Mar 6, 2023
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Feb 22, 2023 Feb 21, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Other events
Dec 29, 2022 Dec 29, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
424B5 Prospectus supplement Oct 20, 2022 —
EFFECT Filing Oct 18, 2022 —
CORRESP Letter to the SEC Oct 13, 2022 —
UPLOAD Letter from the SEC Oct 13, 2022 —
S-3 Shelf registration Oct 7, 2022 —
8-K Current report
Other events
Sep 19, 2022 Sep 16, 2022
S-8 Employee stock plan registration Sep 9, 2022 —
8-K Current report
Material agreement, Unregistered share sale
Aug 10, 2022 Aug 8, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Exit or restructuring costs
Jun 30, 2022 Jun 27, 2022
8-K Current report
Regulation FD disclosure
Jun 14, 2022 Jun 14, 2022
8-K Current report
Shareholder vote results
May 25, 2022 May 24, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
DEF 14A Proxy statement Apr 25, 2022 May 24, 2022
PRE 14A Preliminary proxy statement Apr 14, 2022 May 24, 2022
8-K Current report
Regulation FD disclosure
Mar 25, 2022 Mar 25, 2022
8-K Current report
Other events
Mar 17, 2022 Mar 17, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Other events
Dec 9, 2021 Dec 9, 2021
8-K Current report
Other events
Nov 18, 2021 Nov 18, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
8-K Current report
Other events
Oct 4, 2021 Oct 4, 2021
8-K Current report
Officer or director change
Sep 24, 2021 Sep 20, 2021
S-8 Employee stock plan registration Sep 14, 2021 —
UPLOAD Letter from the SEC Aug 30, 2021 —
CORRESP Letter to the SEC Aug 10, 2021 —
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Auditor change
Aug 2, 2021 Aug 2, 2021
UPLOAD Letter from the SEC Jul 15, 2021 —
8-K Current report
Shareholder vote results
Jun 17, 2021 Jun 17, 2021
S-3ASR Automatic shelf registration May 28, 2021 —
8-K Current report
Material agreement, New debt, Unregistered share sale
May 25, 2021 May 24, 2021
8-K Current report
Other events
May 13, 2021 May 13, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 17, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Regulation FD disclosure
Jan 21, 2021 Jan 21, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Other events
Nov 13, 2020 Nov 13, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 13, 2020 Oct 13, 2020
8-K Current report
Other events
Sep 28, 2020 Sep 28, 2020
8-K Current report
Regulation FD disclosure
Sep 16, 2020 Sep 16, 2020
8-K Current report
Other events
Sep 8, 2020 Sep 8, 2020
8-K Current report
Officer or director change
Aug 5, 2020 Aug 4, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Other events
Jul 24, 2020 Jul 24, 2020
8-K Current report
Other events
Jul 16, 2020 Jul 16, 2020
8-K Current report
Other events
Jun 29, 2020 Jun 29, 2020
8-K Current report
Shareholder vote results
Jun 18, 2020 Jun 17, 2020
8-K Current report
Regulation FD disclosure
Jun 4, 2020 Jun 4, 2020
8-K Current report
Other events
May 18, 2020 May 18, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 23, 2020 Jun 17, 2020
10-K Annual report Mar 2, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
8-K Current report
Other events
Feb 19, 2020 Feb 18, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Material agreement, New debt
Dec 20, 2019 Dec 19, 2019
8-K Current report
Regulation FD disclosure
Dec 16, 2019 Dec 16, 2019
8-K Current report
Other events
Dec 3, 2019 Dec 3, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
8-K Current report
Other events
Oct 28, 2019 Oct 28, 2019
8-K Current report
Other events
Oct 22, 2019 Oct 22, 2019
8-K Current report
Material agreement
Oct 8, 2019 Oct 3, 2019
424B2 Prospectus Oct 7, 2019 —
424B5 Prospectus supplement Oct 3, 2019 —
8-K Current report
Regulation FD disclosure, Other events
Oct 2, 2019 Oct 2, 2019
8-K Current report
Officer or director change
Oct 1, 2019 Oct 1, 2019
8-K Current report
Officer or director change
Oct 1, 2019 Oct 1, 2019
8-K Current report
Other events
Oct 1, 2019 Oct 1, 2019
8-K Current report
Regulation FD disclosure
Aug 20, 2019 Aug 20, 2019
S-8 Employee stock plan registration Aug 5, 2019 —
10-Q Quarterly report Aug 5, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 5, 2019 Aug 5, 2019
8-K Current report
Listing notice, Other events
Jul 17, 2019 Jul 15, 2019
8-K Current report
Shareholder vote results
Jun 19, 2019 Jun 18, 2019
8-K Current report
Regulation FD disclosure
May 21, 2019 May 21, 2019
8-K Current report
Regulation FD disclosure
May 14, 2019 May 14, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
8-K Current report
Other events
May 1, 2019 May 1, 2019
DEFA14A Additional proxy material Apr 26, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HRTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Accelerated filer
SEC CIK
818033
Former names
AP PHARMA INC /DE/ (until Jan 7, 2014); ADVANCED POLYMER SYSTEMS INC /DE/ (until Apr 6, 2001)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.